UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

 

For the month of October 2024

 

Commission File Number: 001-40614

 

INTERCURE LTD.

(Translation of registrant’s name into English)

 

85 Medinat ha-Yehudim Street

Herzliya, 4676670, Israel

Tel: +972 77 460 5012

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

 

 

 
 

 

On October 28, 2024, InterCure Ltd. (the “Company”) convened an Extraordinary General Meeting of Shareholders (the “Extraordinary General Meeting”). However, the Extraordinary General Meeting was adjourned for one week to the same day, time and place due to lack of quorum. Accordingly, the Company’s Extraordinary General Meeting will be reconvened on Monday, November 4, 2024 at 4:00 p.m., Israel time, at the offices of the Company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, at 7 Metsada St., B.S.R Tower 4, Bnei Brak, Israel.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INTERCURE LTD.
   
Date: October 28, 2024 /s/ Amos Cohen
 

Amos Cohen

  Chief Financial Officer

 

 

 

Intercure (NASDAQ:INCR)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Intercure Charts.
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Intercure Charts.